Brief: Medacta H1 Adjusted EBITDA Margin 26.9%
Sep 25 (Reuters) - Medacta H1 revenue growth 14.3%. * H1 adjusted EBITDA EUR 77.5 million * outlook FY revenue growth 13-15%
Recent news on Medacta SA
See all newsBrief: Medacta Group Updates 2026 Guidance, Reiterates 2024-2027 Mid-Term Outlook
Swiss medical device maker Medacta H1 revenue rises on Asia Pacific, EMEA strength
Brief: Medacta H1 Adjusted EBITDA EUR 97 Million
Switzerland's Medacta H1 revenue rises 9.7% in constant currency
Brief: Medacta H1 Revenue EUR 368 Million